3,4-methylenedioxyamphetamine and Renal Insufficiency, Chronic

3,4-methylenedioxyamphetamine has been researched along with Renal Insufficiency, Chronic in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)

Research

Studies (1)

Authors

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Renal Insufficiency, Chronic